Senate committee advances bill requiring insurers that cover transition care to also cover detransition services amid heated debate over reporting and scope

Senate Bill 676, as amended in the Finance Committee on March 24, would require health plans that pay for gender-transition procedures to also cover detransition procedures and would create a reporting requirement for certain providers (defined in the bill as a "gender clinic" or any health-care entity licensed under state law that provides or prescribes gender transition procedures) to submit HIPAA-compliant, deidentified statistics to the Department of Health.

Sponsor remarks (Senator Taylor) and the finance amendment ask the Department of Commerce and Insurance to seek a CMS waiver so detransition services could be treated as an essential health benefit on marketplace plans if parity is required. "If the insurance company offers transition services, then they would be required to offer detransition services," the sponsor said.

Opponents and some committee members pressed multiple issues: Sen. Yarbrough questioned whether transition services are currently defined as an essential health benefit and whether the amendment would effectively expand required benefits for all marketplace plans. Sen. Lamar and others argued the reporting requirement would place data on the department website about a politically sensitive group and compared the billavorably or unfavorably to reporting for other cosmetic surgeries. Sponsor responses stressed that the data would be deidentified and HIPAA-compliant and that the bill aims to provide parity and better information about who is receiving transition and detransition services in Tennessee. The sponsor said discipline for certain unspecified provider violations would include licensing penalties and that reporting would apply whether a patient was insured or self-pay.

Finance adopted two amendments (one seeking the CMS waiver; another with clarifying language aligned with attorney general recommendations). The committee subsequently voted to recommend the bill to the committee on the calendar.

The transcript records extended debate about the policy
nd the public-data implications; members asked whether the Department of Health publishes similar data on cosmetic surgery and whether the bill's reporting would include identifiable patient data (the sponsor said it would not). The committee adopted the finance amendments and advanced the bill for calendar consideration.